• This record comes from PubMed

A1 not A2A adenosine receptors play a role in cortical epileptic afterdischarges in immature rats

. 2014 Nov ; 121 (11) : 1329-36. [epub] 20140514

Language English Country Austria Media print-electronic

Document type Journal Article

Endo- as well as exogenous adenosine exhibits anticonvulsant action. Participation of individual types of adenosine receptors was studied in present experiments in immature rats. Cortical epileptic afterdischarges were used as a model in rat pups 12, 18 and 25 days old. CCPA, an agonist of A1 adenosine receptors, decreased markedly duration of afterdischarges whereas DPCPX, an antagonist of A1 receptors, exhibited strong proconvulsant action. Action of either drug was best expressed in 12-day-old rats and it decreased with age. Drugs influencing A2A adenosine receptors (agonist CGS21680 and antagonist ZM241385) did not exhibit systematic effects in our model. Motor phenomena accompanying cortical stimulation or epileptic afterdischarge were never influenced by any of the four drugs studied. A1 adenosine receptors are important in the model of cortical seizures, especially in the youngest group studied.

See more in PubMed

Eur J Pharmacol. 1999 Apr 29;371(2-3):137-45 PubMed

J Pharm Pharmacol. 1993 Sep;45(9):807-10 PubMed

Epilepsia. 2013 Sep;54 Suppl 6:20-2 PubMed

Physiol Res. 2012;61(6):629-35 PubMed

Brain Res. 1985 Dec 30;361(1-2):309-23 PubMed

J Clin Invest. 2008 Feb;118(2):571-82 PubMed

Brain Res. 1984 Mar;315(1):97-104 PubMed

Brain Dev. 1994 Jul-Aug;16(4):296-300 PubMed

Epilepsy Res. 1996 Nov;25(3):177-84 PubMed

Brain Res Dev Brain Res. 1989 Apr 1;46(2):169-72 PubMed

Neuropharmacology. 2000 Sep;39(12):2418-32 PubMed

Pharmacol Rep. 2010 Jan-Feb;62(1):62-7 PubMed

J Neurochem. 1982 Jul;39(1):267-70 PubMed

Neuroscience. 1997 Oct;80(4):1187-207 PubMed

Eur J Pharmacol. 1997 May 12;326(1):7-14 PubMed

Ann Neurol. 1992 Nov;32(5):618-24 PubMed

Life Sci. 1990;47(1):1-8 PubMed

Epilepsy Behav. 2013 Jul;28(1):113-20 PubMed

Brain Res Brain Res Rev. 1992 May-Aug;17(2):139-70 PubMed

J Neural Transm (Vienna). 2010 Nov;117(11):1269-77 PubMed

Epilepsy Curr. 2013 Jan;13(1):35-7 PubMed

Prog Neurobiol. 2002 Dec;68(6):377-92 PubMed

Physiol Res. 1998;47(2):143-9 PubMed

Br J Pharmacol. 1997 Jan;120(2):282-8 PubMed

Exp Neurol. 1983 Sep;81(3):703-13 PubMed

Exp Neurol. 2009 Sep;219(1):126-35 PubMed

Epilepsy Res. 2000 May;39(3):183-90 PubMed

Brain Res. 1997 Mar 21;751(2):259-64 PubMed

Epilepsy Res. 2002 Mar;49(1):35-43 PubMed

Eur J Pharmacol. 1995 Dec 29;294(2-3):383-9 PubMed

Brain Res. 2010 Oct 14;1356:121-9 PubMed

J Pharmacol Exp Ther. 1982 Jan;220(1):70-6 PubMed

Indian J Exp Biol. 1997 Apr;35(4):342-7 PubMed

Life Sci. 1985 Dec 9;37(23):2205-11 PubMed

Neurosci Res. 2006 Sep;56(1):14-20 PubMed

Prog Neurobiol. 1988;31(2):85-108 PubMed

Exp Neurol. 1976 May;51(2):392-406 PubMed

Seizure. 2011 Mar;20(2):156-9 PubMed

Biochem Pharmacol. 1993 Feb 24;45(4):847-51 PubMed

Epilepsy Res. 1992 Jun;12(1):37-43 PubMed

Psychopharmacology (Berl). 2003 Jul;168(3):299-306 PubMed

Psychopharmacology (Berl). 1994 Jul;115(3):320-4 PubMed

Epilepsy Res. 1994 May;18(1):29-42 PubMed

Int Rev Neurobiol. 2005;63:191-270 PubMed

Handb Exp Pharmacol. 2009;(193):1-24 PubMed

Physiol Res. 2013;62(Suppl 1):S109-14 PubMed

Annu Rev Neurosci. 2001;24:31-55 PubMed

Epilepsia. 2001 May;42(5):577-85 PubMed

Epilepsia. 1996 Apr;37(4):336-41 PubMed

J Neurochem. 1987 Sep;49(3):852-5 PubMed

Epilepsia. 2009 Sep;50(9):2123-9 PubMed

Epilepsy Res. 2002 May;49(3):218-25 PubMed

Neuroscientist. 2005 Feb;11(1):25-36 PubMed

Epilepsia. 1981 Feb;22(1):85-94 PubMed

Neuroscience. 2009 Apr 10;159(4):1408-13 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...